Cargando…
A new tumorgraft panel to accelerate precision medicine in prostate cancer
BACKGROUND: Despite the significant advances in the management of advanced prostate cancer (PCa), metastatic PCa is currently considered incurable. For further investigations in precision treatment, the development of preclinical models representing the complex prostate tumor heterogeneity are manda...
Autores principales: | Béraud, Claire, Bidan, Nadege, Lassalle, Myriam, Lang, Hervé, Lindner, Véronique, Krucker, Clémentine, Masliah-Planchon, Julien, Potiron, Eric, Lluel, Philippe, Massfelder, Thierry, Allory, Yves, Misseri, Yolande |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10250751/ https://www.ncbi.nlm.nih.gov/pubmed/37305585 http://dx.doi.org/10.3389/fonc.2023.1130048 |
Ejemplares similares
-
Integrated molecular and pharmacological characterization of patient-derived xenografts from bladder and ureteral cancers identifies new potential therapies
por: Lang, Hervé, et al.
Publicado: (2022) -
Establishment of a large panel of patient-derived preclinical models of human renal cell carcinoma
por: Lang, Hervé, et al.
Publicado: (2016) -
A renal cell carcinoma tumorgraft platform to advance precision medicine
por: Elias, Roy, et al.
Publicado: (2021) -
Development and Histopathological Characterization of Tumorgraft Models of Pancreatic Ductal Adenocarcinoma
por: Garcia, Patrick L., et al.
Publicado: (2013) -
Genomic characterization of explant tumorgraft models derived from fresh patient tumor tissue
por: Monsma, David J, et al.
Publicado: (2012)